{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:07:07Z","timestamp":1792084027766,"version":"4.4.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Cardiofaciocutaneous syndrome (CFCS) is a rare syndromic disorder caused by germline mutations affecting the RAS\/MAPK pathway. It is characterized by distinctive craniofacial dysmorphism, congenital heart defects, skin abnormalities, gastrointestinal dysfunction, neurocognitive impairment, and epilepsy. Emerging evidence suggests an association with hypogammaglobulinemia, but a comprehensive characterization of immunological abnormalities in CFCS is lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective, multicenter observational study to investigate the immunological phenotype of CFCS. Clinical features, immune-related manifestations, and laboratory parameters were analyzed to delineate the immunological profile of affected individuals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 56 patients with a confirmed clinical and molecular diagnosis of CFCS were included, with a median age at evaluation of 13 years (range: 1\u201339 years). Increased susceptibility to infections was reported in 18\/56 patients (32%), while autoimmune manifestations were observed in 14\/56 patients (25%). Common immunological findings included monocytosis (32%), lymphopenia (21%), and hypogammaglobulinemia, with decreased IgG, IgA, or IgM levels in 21%, 40%, and 35% of patients, respectively. Genotype-phenotype analysis revealed that <jats:italic>BRAF<\/jats:italic> mutations were predominantly associated with T-cell lymphopenia, whereas <jats:italic>MAP2K1<\/jats:italic> mutations were linked to monocytosis, reduced na\u00efve and switched-memory B cells, and hypogammaglobulinemia. Immunodeficiency-related treatments, including immunoglobulin replacement therapy, antibiotic prophylaxis, or immunosuppressive therapy, were administered to 6\/56 patients (11%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>CFCS is associated with recurrent yet heterogeneous immunological abnormalities, including lymphopenia, hypogammaglobulinemia, and increased infection susceptibility. Given these findings, routine immunological assessment should be considered in CFCS patients to facilitate early detection and appropriate management of immune dysfunction.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1598896","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T05:26:46Z","timestamp":1751866006000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort"],"prefix":"10.3389","volume":"16","author":[{"given":"Benedetta Elena","family":"Di Majo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Cartisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germana","family":"Viscogliosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Pia","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Moratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Rigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Rivalta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Cancrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Szczawi\u0144ska-Pop\u0142onyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Jamsheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Obara-Moszy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Zakharova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Shcherbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julija","family":"Rodina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beyhan","family":"T\u00fcys\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya Shekhar","family":"Jamuar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiin Ying","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cereda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Agovino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Contaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luigia","family":"Gambardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Cristina","family":"Balduzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Cherubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Antonio","family":"Marrocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bellesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Carusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Rumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Zampino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Saettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-3189","article-title":"Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines","volume":"134","author":"Pierpont","year":"2014","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/genes14122111","article-title":"The cardiofaciocutaneous syndrome: from genetics to prognostic-therapeutic implications","author":"Scorrano","year":"2023","journal-title":"Genes"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/genes12091316","article-title":"Epilepsy and BRAF mutations: phenotypes, natural history and genotype-phenotype correlations","volume":"12","author":"Battaglia","year":"2021","journal-title":"Genes"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/epi4.12864","article-title":"Status epilepticus in BRAF-related cardio-facio-cutaneous syndrome: Focus on neuroimaging clues to physiopathology","author":"Musto","year":"2024","journal-title":"Epilepsia Open"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.12.1075","article-title":"Update on inborn errors of immunity","volume":"155","author":"IJspeert","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2022.2085830","article-title":"How to recognize inborn errors of immunity in a child presenting with a Malignancy: guidelines for the pediatric hemato-oncologist","volume":"40","author":"Bosch","year":"2023","journal-title":"Pediatr Hematol Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00808-4","article-title":"Prevalence of immunological defects in a cohort of 97 rubinstein-taybi syndrome patients","volume":"40","author":"Saettini","year":"2020","journal-title":"J Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.990111","article-title":"Case report: The cardio-facio-cutaneous syndrome due to a novel germline mutation in MAP2K1: A multifaceted disease with immunodeficiency and short stature","volume":"10","author":"Szczawi\u0144ska-Pop\u0142onyk","year":"2022","journal-title":"Front Pediatr"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/humu.24463","article-title":"Cancer-causing MAP2K1 mutation in a mosaic patient with cardio-facio-cutaneous syndrome and immunodeficiency","volume":"43","author":"Zakharova","year":"2022","journal-title":"Hum Mutat"},{"key":"B10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.imlet.2020.08.009","article-title":"Immunoglobulin deficiency associated with a MAP2K1-related mutation causing cardio-facio-cutaneous syndrome","author":"Leoni","year":"2020","journal-title":"Immunol Letters"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24187","article-title":"Autoimmune neutropenia of infancy: data from the Italian neutropenia registry","volume":"90","author":"Farruggia","year":"2015","journal-title":"Am J Hematol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5812\/pedinfect.31039","article-title":"Diagnosis and management of recurrent respiratory tract infections in children: A practical guide","volume":"4","author":"Schaad","year":"2016","journal-title":"Arch Pediatr Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2011.02609.x","article-title":"Age-matched reference values for B-lymphocyte subpopulations and CVID classifications in children","volume":"74","author":"Schatorj\u00e9","year":"2011","journal-title":"Scand J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.07.003","article-title":"Lymphocyte subsets in healthy children from birth through 18 years of age: The Pediatric AIDS Clinical Trials Group P1009 study","volume":"112","author":"Shearer","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.022350","article-title":"IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents","volume":"49","author":"Schauer","year":"2003","journal-title":"Clin Chem"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-52909-6_10","article-title":"Syndromic immunodeficiencies","volume-title":"Primary immunodeficiency diseases","author":"Ming","year":"2017"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab124","article-title":"Biallelic PI4KA variants cause a novel neurodevelopmental syndrome with hypomyelinating leukodystrophy","author":"Verdura","year":"2021","journal-title":"Brain"},{"key":"B18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10875-024-01793-8","article-title":"Biallelic PI4KA mutations disrupt B-cell metabolism and cause B-cell lymphopenia and hypogammaglobulinemia","author":"Saettini","year":"2024","journal-title":"J Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006441","article-title":"Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency","volume":"137","author":"Saettini","year":"2021","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2023-109438","article-title":"Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement","volume":"61","author":"Lacombe","year":"2024","journal-title":"J Med Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10875-024-01676-y","article-title":"Immunological aspects of kabuki syndrome: A retrospective multicenter study of the Italian primary immunodeficiency network (IPINet)","volume":"44","author":"Rossini","year":"2024","journal-title":"J Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01169-2","article-title":"Immunological evaluation of patients affected with jacobsen syndrome reveals profound not age-related lymphocyte alterations","volume":"42","author":"Baronio","year":"2022","journal-title":"J Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01584-7","article-title":"Antibody deficiency in patients with biallelic KARS1 mutations","volume":"43","author":"Saettini","year":"2023","journal-title":"J Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2018.09.01.1430","article-title":"B cell aplasia and hypogammaglobulinemia associated with levetiracetam","volume":"38","author":"Ozdemir","year":"2018","journal-title":"Ann Saudi Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.49.3087","article-title":"B cell aplasia and hypogammaglobulinemia after carbamazepine treatment","volume":"49","author":"Yamamoto","year":"2010","journal-title":"Internal Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-012-1153-3","article-title":"Valproate-induced panhypogammaglobulinemia","volume":"34","author":"Eom","year":"2013","journal-title":"Neurological Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/00365540260348662","article-title":"Reversible panhypogammaglobulinemia associated with phenytoin treatment","volume":"34","author":"Pereira","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000689","article-title":"Primary immune regulatory disorders: a growing universe of immune dysregulation","volume":"20","author":"Chan","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.08.001","article-title":"BRAF mutants evade ERK-dependent feedback by different mechanisms that determine their sensitivity to pharmacologic inhibition","volume":"28","author":"Yao","year":"2015","journal-title":"Cancer Cell"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nature23291","article-title":"Tumors with class 3 BRAF mutants are sensitive to the inhibition of activated RAS","volume":"548","author":"Yao","year":"2017","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1452","article-title":"Allele-specific mechanisms of activation of MEK1 mutants determine their properties","volume":"8","author":"Gao","year":"2018","journal-title":"Cancer Discov"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-22-0302","article-title":"High-throughput functional evaluation of MAP2K1 variants in cancer","volume":"22","author":"Mizuno","year":"2023","journal-title":"Mol Cancer Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1016\/j.molcel.2022.10.016","article-title":"RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulation","volume":"82","author":"Spencer-Smith","year":"2022","journal-title":"Mol Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.04.004","article-title":"Neurologic and neurodevelopmental complications in cardiofaciocutaneous syndrome are associated with genotype: A multinational cohort study","volume":"24","author":"Pierpont","year":"2022","journal-title":"Genet Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.1124642","article-title":"Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome","volume":"311","author":"Rodriguez-Viciana","year":"2006","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI181604","article-title":"Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERK-mediated monocyte activation","volume":"134","author":"Bohlen","year":"2024","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.935951","article-title":"Abnormal B-cell maturation and increased transitional B cells in CBL syndrome","volume":"10","author":"Saettini","year":"2022","journal-title":"Front Pediatr"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144369","article-title":"Cardio-facio-cutaneous syndrome-associated pathogenic MAP2K1 variants activate autophagy","volume":"733","author":"Chen","year":"2020","journal-title":"Gene"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131053","article-title":"HRAS germline mutations impair LKB1\/AMPK signaling and mitochondrial homeostasis in Costello syndrome models","volume":"132","author":"Dard","year":"2022","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2010.171","article-title":"Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway","volume":"19","author":"Kleefstra","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jacbts.2024.10.002","article-title":"Impact of MEK inhibition on childhood RASopathy-associated hypertrophic cardiomyopathy","volume":"10","author":"Wolf","year":"2024","journal-title":"J Am Coll Cardiol Basic Trans Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/children11111342","article-title":"Refractory chylothorax and ventricular hypertrophy treated with trametinib in a patient with noonan syndrome: 18-month follow-up","author":"Pascarella","year":"2024","journal-title":"Children"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/life14060731","article-title":"Exploring new drug repurposing opportunities for MEK inhibitors in RASopathies: A comprehensive review of safety, efficacy, and future perspectives of trametinib and selumetinib","author":"Gazzin","year":"2024","journal-title":"Life"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1001105","article-title":"Case Report: Progressive central conducting lymphatic abnormalities in the RASopathies. Two case reports, including successful treatment by MEK inhibition","author":"Gordon","year":"2022","journal-title":"Front Genet"},{"key":"B45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa1516767","article-title":"Resolution of disease phenotypes resulting from multilocus genomic variation","volume":"376","author":"Posey","year":"2017","journal-title":"N Engl J Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.05.042","article-title":"Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders","volume":"139","author":"Stray-Pedersen","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16967","article-title":"More than an \u2018atypical\u2019 phenotype: dual molecular diagnosis of autoimmune lymphoproliferative syndrome and Becker muscular dystrophy","volume":"191","author":"Saettini","year":"2020","journal-title":"Br J Hematol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1598896\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T05:26:47Z","timestamp":1751866007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1598896\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2025.1598896"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1598896","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"article-number":"1598896"}}